Crowdonomics
All companies
REUZEIT logo

REUZEIT

Operating

REUZEit, Inc.

Healthcare · Temecula, CA · Founded 2020

Circular economic surplus asset management

Post-money valuation ⓘ
$40.2M
As of Feb 2023 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$159,676
Across 1 round since 2022
Latest share price
$0.80
Reg CF · Common Stock · Nov 2022 offering price

Financials

FY2020–FY2022 · from SEC filings · hover any figure for its source
$6.9M
$910K
2020
$6.4M
−$279K
2021
$7.8M
−$385K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed
FY2021 reviewed
FY2022
Income statement
Revenue
$6,884,892
$6,420,789
$7,801,733
Cost of goods sold
$3,190,768
$3,296,877
$2,981,614
Gross margin
54%
49%
62%
Net income
$910,436
-$278,668
-$384,847
Taxes paid
$115,611
$32,620
$641
Balance sheet
Cash
$566,326
$378,941
$327,379
Accounts receivable
$348,369
$713,164
$1,990,824
Total assets
$1,553,762
$2,164,354
$3,592,235
Short-term debt
$663,847
$1,367,104
$1,767,175
Long-term debt
$141,228
$261,034
$1,529,687
Total liabilities
$805,075
$1,628,138
$3,296,862
Other
Headcount
—
27
27

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$40.0M
pre-money
Reg CF · Common · Nov 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Share counts as of Dec 31, 2022
ClassOutstandingVotes / shareShare of totalLast price
Common stock46,275,981—100.0%$0.80Nov 2022

Shares outstanding over timein today's share terms

49M24M0
Dec 2020Dec 2022
Common stockRound opened

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $159.7K / $1.2MInvestors 68Post-money $40.2M

Team

8 people
Justin AndrewsFounder
Chief Executive Officer & Co-Founder

Justin’s shared vision for a circular economic surplus asset management program was the basis for REUZEit’s founding. He is a self-propelled innovator, building and delivering on key strategy, and software vision. He spearheaded REUZEit’s expansion into the European market by establishing locations in both the Netherlands and UK.

Ryan AndrewsFounder
Chief Innovation Officer & Co-Founder

Ryan is a vibrant, problem-solving visionary with extensive knowledge of the life sciences and pharmaceutical industries. He is on a mission to empower all organizations in all capital asset industries to achieve their productivity and sustainability goals by leveraging previously uncaptured value through surplus asset management.

Casi Mayo
Chief Operations Officer

Casi is a serial entrepreneur with a pedigree from elite Silicon Valley VCs. Building upon her studies at Berkeley, she brought 20+ years of accounting and business acumen to organize and establish SOPs in finance and business scalability. Casi truly is the connective layer for all internal operations.

Dave Ward
Chief Strategy Officer

Dave has 30 years of industry and consulting experience with Fortune 100 and mid-market companies. He has functional experience in corporate strategy, business development, supply chain, global sourcing, product development, product management, M&A, and finance. His industry experience ranges from consumer products, retail, footwear, apparel, sporting goods, and the industrial sectors. He lends a global perspective through his 20+ years of living and working overseas in APAC, EMEA, and LATAM.

Jonah Shell
Chief Sustainability Officer

Jonah joined the company full-time shortly after earning his MBA with a focus on Business Sustainability and Renewable Energy. He began by developing the company’s marketing and sales processes and managing key relationships with strategic buyers and high-ticket sales using his 20+ years of proven sales team leadership in B2B and B2C structures. He now oversees REUZEit's R&D, sustainability reporting with an emphasis on GHG emission reduction, case studies, and co-authors REUZEit-published white papers.

Mike Kish
Director, Global Business Development and Client Services

Mike is a Senior Level Sales/Marketing/Business Development Executive with robust experience in consumer marketing and brand development across multiple platforms. He has over 20 years of experience in brand management with an emphasis on strategy development/implementation, situational analysis, consumer analytics, and team leadership. Additional specialties include sales/distribution strategy, large-scale budgeting, public speaking, and developing strategic partnerships.

Nick Velis
Senior Program Manager

With 15+ years in operations, account management, and logistics, Nick works directly with REUZEit’s diverse clientele with account onboarding, process management, and any other specific requests they may have. He is the lead manager of our client's Trade-In programs. Nick is one of the original team members from the early days of REUZEit, formerly known as ANDbio.

Steve Balmer
Sales Director

With over 20+ years of sales experience with both Fortune 1000 and start-up companies, Steve leads new business sales revenue for the company. Steve has proven success in leading collaborative efforts between cross-functional departments to improve omnichannel results. Accomplished in building and leading high-performing sales teams. Steve believes the key to success is a relentless commitment to cultivating curiosity and growth for his team.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 4 annual reports (FY2022–FY2025)

68 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMay 1, 20230001665160-23-001142
    EDGAR
  • Form C-UFeb 17, 20230001665160-23-000267
    EDGAR
  • Form CNov 17, 20220001665160-22-002933
    EDGAR
Source: ManualCIK 0001949602CAShare price $0.80

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.